Citation Impact
Citing Papers
Adding loratadine to topical nasal steroid therapy improves moderately severe seasonal allergic rhinoconjunctivitis
1995
Novel Controlled-Release Lemna -Derived IFN- α 2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial
2008
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications
1997
An overview of the recent developments in polylactide (PLA) research
2010 Standout
SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis
1989
Loratadine
1989
Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving
1992
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Improving drug solubility for oral delivery using solid dispersions
2000 Standout
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
1999 Standout
Microemulsion-based media as novel drug delivery systems
2000 Standout
Clinical Pharmacology of New Histamiine H1 Receptor Antagonists
1999
Polyphosphoesters in drug and gene delivery
2003
Albumin–drug interaction and its clinical implication
2013 Standout
Comparison of the effects of levocetirizine and loratadine on histamine‐induced wheal, flare, and itch in human skin
2001
Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis
1997
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Effects of corticosterone on muscle mitochondria identifying different sensitivity to glucocorticoids in Lewis and Fischer rats
2004
Mechanisms of neurotransmitter release by amphetamines: A review
2005 Standout
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of Interferon
1998
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Central nervous system effects of H1-receptor antagonists in the elderly
1999
The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline
1987
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Cancer nanotechnology: opportunities and challenges
2005 Standout
Optimum Treatment of Rhinitis in the Elderly
1995
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract1PII of original article: S0169-409X(96)00487-5. The article was originally published in Advanced Drug Delivery Reviews 25 (1997) 3–14.1
2001
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Update on the Management of Onychomycosis: Highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy
1996
Circadian control of the immune system
2013 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Microfluidic organs-on-chips
2014 Standout
In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants
1989
How nutrition and the maternal microbiota shape the neonatal immune system
2017
Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism
2006
Interferon-α2b Secretion by Adenovirus-Mediated Gene Delivery in Rat, Rabbit, and Chimpanzee Results in Similar Pharmacokinetic Profiles
2002
The molecular logic of endocannabinoid signalling
2003 Standout
Clinical Pharmacokinetics of Interferons
1990
Metabolomics-on-a-Chip of Hepatotoxicity Induced by Anticancer Drug Flutamide and Its Active Metabolite Hydroxyflutamide Using HepG2/C3a Microfluidic Biochips
2012
Antifungal agents: An overview. Part II
1994
Interactions of the Nonsedating Antihistamine Loratadine with a Kv1.5-Type Potassium Channel Cloned from Human Heart
1997
Lack of subsensitivity to loratadine during long-term dosing during 12 weeks
1990
Herbal Medicines and Perioperative Care
2001 Standout
Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations*
1995
Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended‐Release Tablets in Healthy Volunteers
1996
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia
2014 StandoutNobel
Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins
2005
Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FcepsilonRI+ cells
1997
Modeling and comparison of dissolution profiles
2001 Standout
Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier
2002
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
1995 Standout
Evaluation of the Histamine H1-Antagonist-Induced Place Preference in Rats.
1999
Second-Generation Antihistamines
1999
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
1991
Preparation and Dissolution Characteristics of Several Fast-Release Solid Dispersions of Griseofulvin
1969
Particle Size of Drugs and Its Relationship to Absorption and Activity
1968
3d Transition Metals for C–H Activation
2018 Standout
Antifungal agents: An overview. Part I
1994
Mixing-Tank Model for Predicting Dissolution Rate Control of Oral Absorption
1986
Copper Active Sites in Biology
2014 Standout
Formation of dopamine from 3-methoxytyrosine
1972 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults
1979
Strategies in Herbivory by Mammals: The Role of Plant Secondary Compounds
1974 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Accessing Drug Metabolites via Transition‐Metal Catalyzed C−H Oxidation: The Liver as Synthetic Inspiration
2016
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis
1990
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Microfabricated Drug Delivery Systems: Concepts to Improve Clinical Benefit
2001
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
2001
Metabolism of Some Kava Pyrones in the Rat
1979
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function
1998
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
1976
The pharmacological and anatomical substrates of the amphetamine response in the rat
1975
Biodegradable polymers as biomaterials
2007 Standout
Transport phenomena in nanofluidics
2008 Standout
Fourteen-Member Macrolides Suppress Interleukin-8 Production but Do Not Promote Apoptosis of Activated Neutrophils
2002 StandoutNobel
Ceftibuten Resistance and Treatment Failure ofNeisseria gonorrhoeaeInfection
2008
Drug Metabolism by Intestinal Microorganisms
1968
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
1975 Standout
Pharmaceutical Applications of Solid Dispersion Systems
1971 Standout
Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cells
1997
A psychomotor stimulant theory of addiction.
1987 Standout
Blood platelets as a model for monoamine-containing neurones
1973
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
New inhibitors of dopamine β-hydroxylase
1977
Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission
1996
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Applications of isotope dilution‐mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology
1992
Depletion of dopamine in the striatum as an experimental model of parkinsonism: direct effects and adaptive mechanisms
1982
Pharmacokinetics of Oral Decongestants
1993
Oral Absorption of Griseofulvin in Dogs: Increased Absorption via Solid Dispersion - in Polyethylene Glycol 6000
1970
Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations
1985 StandoutNobel
Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and Capsules
1969
New Data on the Safety of Loratadine
1992
Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission.
1996
Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats
1992
Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog
1981 StandoutNobel
Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets
1975
Diazoxide in treatment of primary pulmonary hypertension.
1978
A Source of Error in Catecholamine Turnover Studies with Labelled DOPA: Slow Disappearance of the Precursor
1970
Works of Samson Symchowicz being referenced
Disposition and metabolic fate of 14C-quazepam in man.
1985
Loratadine: Multiple‐Dose Pharmacokinetics
1987
Comparative steady state bioavailability of conventional and controlled‐release formulations of albuterol
1987
Pharmacokinetics of Interferon α‐2b in Healthy Volunteers
1987
Excretion of Loratadine in Human Breast Milk
1988
Pharmacokinetics and Dose Proportionality of Loratadine
1987
The Pharmacokinetics of Loratadine in Normal Geriatric Volunteers
1988
Influence of food on the absorption of albuterol Repetabs
1989
The pharmacokinetics of ceftibuten in humans
1991
Placental transfer of quazepam in mice.
1986
Steady-State Bioavailability of Dexbrompheniramine and Pseudoephedrine from a Repeat-Action Combination Tablet
1985
Norepinephrine biosynthesis in the rat pancreas
1968
Effect of dexamethasone on monoamine oxidase inhibition by iproniazid in rat brain
1977
ABSORPTION, METABOLISM AND EXCRETION OF 14C-GRISEOFULVIN IN MAN
1973
Quazepam kinetics in the elderly
1984
Diazoxide blood levels in man
1967
Griseofulvin Absorption in Man After Single and Repeated Treatments and Its Correlation with Dissolution Rates
1968
Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogs
1971
Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
1974
Oxidative demethylation of 14C-griseofulvin by liver microsomes of rats and mice
1973
Single and Multiple Dose Pharmacokinetic Evaluation of Flutamide in Normal Geriatric Volunteers
1989
The effect of cocaine and imipramine on tyramine‐induced release of noradrenaline‐3H from the rat vas deferensin vitro
1969
Plasma binding of betamethasone3H, dexamethasone-3H, and cortisol-14C— A comparative study
1969
Comparative Bioavailability and Pharmacokinetics of Three Formulations of Albuterol
1985
Absorption, Distribution, Metabolism, and Excretion of Griseofulvin in Man and Animals
1975
Correlation of dissolution rate and griseofulvin absorption in man
1967
A comparative study of griseofulvin-14c metabolism in the rat and rabbit
1967